Company / Operating Cash Flow
Zoetis Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$2.9B
FY2025
5-year range
$1.8B / $3.0B
FY2021-FY2025
Trend
-1.7%
vs FY2024
Sector context
#12 of 216
Health Care
What the data says
Among 216 Health Care companies, Zoetis is in the top 6% for operating cash flow. Operating Cash Flow has fluctuated over the past 10 years, ranging from $626M in FY2016 to $3.0B in FY2024.
Based on SEC 10-K filings.
$2.9B in FY2025 with a 5-year CAGR of +10.2%. Top quartile in the Health Care sector.
Improved from $2.2B to $2.9B over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +11.0%
- 5-Year CAGR
- +10.2%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 216This company $2.9B Sector average $658.7M
▼
+340.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +10.2%, indicating consistent growth.
- In FY2025, operating cash flow decreased 1.7% year-over-year.
- Ranks #12 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2024.
Company context
Key Data Points
- Strong profit margin: 28.2%
- Strong return on equity: 49.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.9B | -1.7% |
| FY2024 | $3.0B | +33.4% |
| FY2023 | $2.2B | +4.1% |
| FY2022 | $2.1B | +18.4% |
| FY2021 | $1.8B | +0.3% |
| FY2020 | $1.8B | -0.3% |
| FY2019 | $1.8B | +0.3% |
| FY2018 | $1.8B | +169.6% |
| FY2017 | $664.0M | +6.1% |
| FY2016 | $626.0M | -8.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026